Theralase® Announces Warrant Extension

TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on […]

Read More

Almadex Announces Warrant Extension

VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) announces that, subject to [...]

Read More